Pharmacopeia Home Page: Pharmacopeia

Pharmacopeia

Company Overview

Pipeline

Partnering

Discovery & Development

Investors

News & Events

Careers & Culture

Nov 07, 2008
Pharmacopeia to Request a Hearing With NASDAQ Following Receipt of Notice of Non-Compliance

Nov 06, 2008
Pharmacopeia Announces Third Quarter 2008 Financial Results

Pharmacopeia is a biopharmaceutical company, focused on the creation of new small molecule therapeutics to address significant unmet medical needs.

© 2009 Pharmacopeia, Inc.

Business Strategy
Corporate Officers
Board of Directors

DARA - PS433540
CXCR2 - PS291822
p38 - PS540446
SCH727965 - PS095760
SARM - PS178990
PS386113
PS948115
PS873266
CCR1 - PS031291
PS015146
JAK3 - Wyeth
JAK3 - Pharmacopeia

Alliances & Collaborations
In-licensing
Out-licensing

Lead Discovery
Lead Optimization
Preclinical Development
Clinical Development

Financial Statements
SEC Filings
Corporate Governance
Board Committees
Information Request

Press Releases
Media Contacts
Posters & Presentations

Working at Pharmacopeia
Benefits
Positions